1. Home
  2. Vol 28, No 4 (2024)
  3. Elkareem

Clinical and genetic characteristics of disorders of sex development in Sudanese patients

Manal M.E.A. Elkareem(1), Houda M. Dguimi(2), Samia M. Ahmed(3), Rayan Khalid(4), Imad Fadl-Elmula(5),


(1) Department of Biology, Faculty of Sciences, Al-Baha University, Saudi Arabia
(2) Department of Biology, Faculty of Sciences, Al-Baha University, Saudi Arabia
(3) Department of Medical Laboratories, College of Applied Medical Sciences, Taibah University, Almadeena Almonawara, Saudi Arabia
(4) Department of Clinical Genetics, Al Neelain Stem Cell Center, Al Neelain University, Khartoum, Sudan
(5) Department of Clinical Genetics, Assafa College, Khartoum-Sudan
Corresponding Author

Abstract


Given the scarce data on DSD in Sudan, we aimed to characterize DSD's clinical and genetic profile in Sudanese patients. We studied 60 patients with DSD using clinical data, cytogenetics, and PCR for the SRY gene. The results showed that 65% grew up as females and 35% as males. There was a high percentage of consanguineous parents (85%). Female genital mutilation (FGM) was performed in 75% of females. Patients who presented after pubertal age were 63%, with ambiguous genitalia in 61.7%, followed by primary amenorrhea (PA) in 30%. The SRY gene was positive in 3.3% of patients with 46,XX karyotype and negative in 6.7% of patients with 46,XY karyotype. 5αR2D-DSD was seen in 43.3%, gonadal dysgenesis in 21.7%, Ovotesticular syndrome in 6.7%, Swyer and Turner syndrome in 5% each, and Androgen Insensitivity Syndrome (AIS) in 3.3%. In conclusion, DSD in Sudan has a distinct profile with late presentation, dominated by 5αR2D-DSD due to the increased consanguineous marriage, and FGM represents a significant risk for DSD patients. (Afr J Reprod Health 2024; 28 [4]: 13-21).

References


Lee PA, Nordenström A, Houk CP, Ahmed SF, Auchus R,

Baratz A, Baratz Dalke K, Liao LM, Lin-Su K and

Mazur T. Global disorders of sex development update

since 2006: perceptions, approach and care. Hormone

research in paediatrics. 2016;85(3):158–80.

ALOmran HI and ALJurayyan NA. Disorders of Sex

Development (DSD): Diagnostic Approach and

Management in Infants and Children. Biomedical

Journal of Scientific & Technical Research.

;36(5):28940–50.

Woodward M and Patwardhan N. Disorders of sex

development. Surgery (Oxford). 2010;28(8):396–401.

Berta P, Hawkins JB, Sinclair AH, Taylor A, Griffiths BL,

Goodfellow PN and Fellous M. Genetic evidence

equating SRY and the testis-determining factor.

Nature. 1990;348(6300):448–50.

Xue M, Wang X, Li C, Zhao M, He F and Li X. Novel

pathogenic mutations in disorders of sex development

associated genes cause 46, XY complete gonadal

dysgenesis. Gene. 2019;718:144072.

Cools M, Looijenga LHJ, Wolffenbuttel KP and Drop SLS.

Disorders of sex development: update on the genetic

background, terminology and risk for the

development of germ cell tumors. World J Pediatr.

May;5(2):93–102.

Rouzi AA and Alturki F. Female genital mutilation/cutting:

an update. Clinical and experimental obstetrics &

gynecology. 2015;42(3):300–3.

Abdullah MA, Saeed U, Abass A, Lubna K, Weam A, Ali AS

and Elmwla IF. Disorders of sex development among

Sudanese children: 5-year experience of a pediatric endocrinology clinic. Journal of Pediatric

Endocrinology and Metabolism. 2012;25(11–

:1065–72.

Zainuddin AA and Mahdy ZA. The Islamic Perspectives of

Gender-Related Issues in the Management of Patients

With Disorders of Sex Development. Arch Sex Behav.

Feb;46(2):353–60.

McGowan-Jordan J, Hastings R and Moore S. Re:

International system for human cytogenetic or

cytogenomic nomenclature (ISCN): some thoughts,

by T. Liehr. Cytogenetic and Genome Research.

;161(5):225–6.

Sinclair MC and Aitken R. PCR strategies for isolation of

the 5′ end of an immunoglobulin-encoding bovine

cDNA. Gene. 1995;167(1–2):285–9.

Preves SE. Unruly bodies: Intersex variations of sex

development. In: Introducing the New Sexuality

Studies. Routledge; 2011. p. 143–9.

Ekpokai TB. Intersexuality and decision making of Nigerian

parents. 2017.

Ahmed SM and Fadl-Elmula I. Clinical, cytogenetic, and

molecular characterization of disorders of sexual

development (DSD) in Sudan. Genomics and Applied

Biology. 2016;6.

Pal AK, Ambulkar PS, Sontakke BR, Talhar SS, Bokariya P

and Gujar VK. A study on chromosomal analysis of

patients with primary amenorrhea. Journal of human

reproductive sciences. 2019;12(1):29.

Meijer RP and Groeneveld AE. Intersex: Four cases in one

family. Journal of Pediatric Urology. 2007;3(2):

–41.

Pearlman A, Loke J, Le Caignec C, White S, Chin L,

Friedman A, Warr N, Willan J, Brauer D and Farmer

C. Mutations in MAP3K1 cause 46, XY disorders of

sex development and implicate a common signal

transduction pathway in human testis determination.

The American Journal of Human Genetics.

;87(6):898–904.

Majumdar I and Mazur T. Management of Infants Born with

Disorders/Differences of Sex Development. In:

Radovick S, Misra M, editors. Pediatric

Endocrinology. Cham: Springer International

Publishing; 2018. p. 617–39.

Unicef. Female Genital Mutilation/cutting: a Global

Concern. UNICEF’s Data Work on FGM/C. Unicef;

Ellaithi M, Gisselsson D, Nilsson T, Elagib A and FadlElmula I. Overview on the first human cytogenetic

research in Sudan. Sudan Journal of Medical Sciences.

;1(1):25–33.

Adam MP, Fechner PY, Ramsdell LA, Badaru A, Grady RE,

Pagon RA, McCauley E, Cheng EY, Parisi MA and

Shnorhavorian M. Ambiguous genitalia: What

prenatal genetic testing is practical? American J of

Med Genetics Pt A. 2012 Jun;158A(6):1337–43.

Douglas G, Axelrad ME, Brandt ML, Crabtree E, Dietrich

JE, French S, Gunn S, Karaviti L, Lopez ME, Macias

CG, McCullough LB, Suresh D and Sutton VR.

Consensus in Guidelines for Evaluation of DSD by the

Texas Children’s Hospital Multidisciplinary Gender

Medicine Team. International Journal of Pediatric

Endocrinology. 2010;2010:1–17.

Granada ML and Audí L. The laboratory in the

multidisciplinary diagnosis of differences or disorders

of sex development (DSD): I) Physiology,

classification, approach, and methodologyII)

Biochemical and genetic markers in 46,XX DSD.

Advances in Laboratory Medicine / Avances en

Medicina de Laboratorio. 2021 Nov 29;2(4):468–80.


Full Text: PDF

Article Metrics

Abstract View : 864 times
PDF Download : 289 times

Refbacks

  • There are currently no refbacks.